DAX19.626 +1,0%ESt504.804 +1,0%MSCIW3.810 +0,6%Dow44.911 +0,4%Nas19.218 +0,8%Bitcoin90.773 -0,5%Euro1,0578 +0,3%Öl72,94 -0,3%Gold2.650 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Tesla A1CX3T Siemens Energy ENER6Y Rheinmetall 703000 Deutsche Telekom 555750 Bayer BAY001 Volkswagen (VW) vz. 766403 Amazon 906866 MicroStrategy 722713 Mercedes-Benz Group (ex Daimler) 710000 Palantir A2QA4J Apple 865985 BASF BASF11 BioNTech (ADRs) A2PSR2 Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht freundlich ins Wochenende -- US-Börsen schließen auf Rekordhoch -- Delivery Hero setzt Talabat-IPO-Preis fest -- EVOTEC-COO scheidet zum Jahresende aus -- Bitcoin, KION, HSBC, VW im Fokus
Top News
KW 48: Tops und Flops der TecDAX-Aktien in der vergangenen Woche KW 48: Tops und Flops der TecDAX-Aktien in der vergangenen Woche
KW 48: Die Gewinner und Verlierer der MDAX-Aktien der vergangenen Woche KW 48: Die Gewinner und Verlierer der MDAX-Aktien der vergangenen Woche
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Nicox Aktie

NeuKaufenVerkaufen
0,1700 EUR +0,0080 EUR +4,94 %
FSE
0,4290 EUR +0,0230 EUR +5,67 %
LSE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.15,12 Mio. EUR

Div. Rendite0,00%

WKNA143G8

ISINFR0013018124

SymbolNICXF

Nicox Aktien News

DatumMeistgelesen
GlobeNewswireMonthly Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights as of August 31, 2023
GlobeNewswireMonthly Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights
GlobeNewswireNicox Provides Second Quarter 2023 Financial and Business Highlights
GlobeNewswireNicox: Half-year liquidity contract statement with Kepler Cheuvreux
GlobeNewswireNicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million
GlobeNewswireMONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS
GlobeNewswireNicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress
GlobeNewswireNicox: 2023 Ordinary Shareholder Meeting
GlobeNewswireMonthly Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights
GlobeNewswireNumber of voting rights as of April 30, 2023
GlobeNewswireNicox’s Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China
GlobeNewswireTransfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023
GlobeNewswireNew Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at ARVO 2023
GlobeNewswireNumber of voting rigts as of April 24, 2023
GlobeNewswireNicox: 2023 Ordinary Shareholder Meeting to be held on June 1st, 2023
GlobeNewswireNicox Provides First Quarter 2023 Financial and Business Highlights
GlobeNewswireAdditional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China
GlobeNewswirePublication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights as of March 31, 2023
GlobeNewswireNicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucoma Congress
GlobeNewswireNicox Reports 2022 Financial Results and Updates Key Future Milestones
GlobeNewswireNicox to Present at Upcoming Scientific Conferences
GlobeNewswireNumber of voting rights as of February 28, 2023
GlobeNewswireNicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all Resolutions
GlobeNewswireNicox’s Ordinary Shareholder Meeting to be held on February 28, 2023
GlobeNewswireNicox Raises €10 Million in Private Placement
GlobeNewswireNicox Raises €10 Million in Private Placemen
GlobeNewswireNicox Outlines Future Development and Partnering Plans for NCX 470 in Glaucoma
GlobeNewswireNicox Reports Achieving Primary Objective in Mont Blanc, the First Phase 3 Glaucoma Trial for NCX 470
GlobeNewswireNicox Provides Third Quarter 2022 Financial and Business Highlights
GlobeNewswireNicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial
GlobeNewswireNicox Provides First Half 2022 Business Update and Financial Results
GlobeNewswireNicox to Participate in Financial and Scientific Events in Q3 2022
GlobeNewswireNicox Appoints Jean-Francois Labbé as Chairman of the Board of Directors
GlobeNewswireNicox Provides Second Quarter 2022 Financial and Business Highlights
GlobeNewswireNicox: 2022 Extraordinary Shareholder Meeting
GlobeNewswireNicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular Hemodynamics and Retinal Cell Physiology
GlobeNewswireNicox: 2022 Extraordinary Shareholder Meeting
GlobeNewswireNicox Accelerates Topline Results from NCX 470 Mont Blanc Phase 3 Glaucoma Trial to November 2022
EQS GroupNicox (COX): Eye health portfolio targets large markets
GlobeNewswireNicox Announces a New Governance Structure

Nicox News

Nicox News: auf dieser Seite finden Sie alle Nicox News und Nachrichten zur Nicox Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Nicox News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Nicox News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.